Your search returned 38 results. Subscribe to this search

Not what you expected? Check for suggestions
|
21. Outcomes in Treatment-Naïve Patients With Metastatic Extremity Osteosarcoma Treated With OGS-12, a Novel Non-High-Dose Methotrexate-Based, Dose-Dense Combination Chemotherapy, in a Tertiary Care Cancer Center.

by Bajpai J [Corresponding author] | Chandrasekharan A | Simha V | Talreja V | Karpe A | Pandey N | Singh A | Rekhi B | Vora T | Ghosh J | Banavali S | Gupta S.

In Journal of Global Oncology.
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

22. P3.02b-007 Differential Efficacy of Gefitinib in Exon 19 or Exon 21 Mutated Adenocarcinoma Lung

by Goel A | Joshi A | Patil V | Noronha V | Chougule A | Mahajan A | Janu A | Kaushal R | Goud S | More S | Karpe A | Ramaswamy A | Pande N | Chandrasekharan A | Talreja V | Chanana R | Prabhash K.

In Journal of Thoracic Oncology
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

23. P3.02b-055 Impact of pemetrexed chemotherapy in exon 19 or exon 21 mutated nsclc

by Talreja V | Noronha V | Patil V | Joshi A | Chougule A | Mahajan A | Janu A | Goud S | More S | Karpe A | Ramaswamy A | Pande N | Chandrasekharan A | Goel A | Prabhash K.

In Journal of Thoracic Oncology
Material type: article Article; Format: print Publisher: New York, NY : Elsevier 2017Online access: PDF Availability: Items available for loan: Tata Memorial Hospital (1).

24. P3.02b-058 Second-Line Therapy in EGFR Activating Mutation Positive Advanced NSCLC: Analysis from a Randomized Phase III First-Line Trial

by Ramaswamy A | Patil V | Joshi A | Noronha V | Choughule A | Mahajan A | Goud S | More S | Karpe A | Pande N | Chandrasekharan A | Goel A | Talreja V | Prabhash K.

In Journal of Thoracic Oncology
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

25. P3.02b-090 Pemetrexed versus gefitinib in egfr mutation positive lung cancer: results of a phase 3 study from India

by Kumar Prabhash | Patil V | Joshi A | Noronha V | Chougule A | Mahajan A | Janu A | Goud S | More S | Kaushal R | Karpe A | Ramaswamy A | Pande N | Talreja V.

In Journal of Thoracic Oncology
Material type: article Article; Format: print Publisher: New York, NY : Elsevier 2017Online access: PDF Availability: Items available for loan: Tata Memorial Hospital (1).

26. Palliative chemotherapy in carcinoma nasopharynx

by Patil VM | Joshi A | Noronha V | Talreja V | Simha V | Dhumal S | Bandekar B | Chandrasekharan A | Kumar Prabhash [Corresponding Author].

In South Asian Journal of Cancer
Material type: article Article; Format: print Publisher: 2019Availability: Items available for loan: Tata Memorial Hospital (1).

27. Perioperative epirubicin, oxaliplatin, and capecitabine chemotherapy in locally advanced gastric cancer: safety and feasibility in an Interim survival analysis

by Ostwal V [Corresponding author] | Sahu A | Ramaswamy A | Sirohi B | Bose S | Talreja V | Goel M | Patkar S | Desouza A | Shrikhande SV.

In Journal of Gastric Cancer
Material type: article Article; Format: print Publisher: Seoul : Korean Gastric Cancer Association 2017Online access: PDF Availability: Items available for loan: Tata Memorial Hospital (1).

28. Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer

by Patil VM | Noronha V | Joshi A | Dhumal S | Mahimkar M | Bhattacharjee A | Gota V | Pandey M | Menon N | Mahajan A | Sable N | Kumar S | Nawale K | Mukadam S | Solanki B | Das S | Simha V | Abraham G | Chandrasekharan A | Talreja V | DSouza H | Srinivas S | Kashyap L | Banavali S | Prabhash K [Corresponding Author].

In Journal of Clinical Oncology
Material type: article Article; Format: print Publisher: 2019Availability: Items available for loan: Tata Memorial Hospital (1).

29. Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma

by Patil VM | Noronha V | Joshi A | Choughule AB | Bhattacharjee A | Kumar R | Goud S | More S | Ramaswamy A | Karpe A | Pande N | Chandrasekharan A | Goel A | Talreja V | Mahajan A | Janu A | Purandare N | Prabhash K [Corresponding author].

In ESMO Open
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

30. PUB118 Pre-chemotherapy EGFR mutation status & outcomes with second line gefitinib in advanced adenocarcinoma lung

by Karpe A | Noronha V | Patil V | Joshi A | Chougule A | Janu A | More S | Goud S | Ramaswamy A | Pande N | Chandrasekharan A | Goel A | Talreja V | Prabhash K.

In Journal of Thoracic Oncology
Material type: article Article; Format: print Publisher: New York: Elsevier 2017Online access: PDF Availability: Items available for loan: Tata Memorial Hospital (1).

31. Quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of a Phase III randomized trial to compare the benefit of gefitinib versus pemetrexed/ carboplatin for epidermal growth factor receptor-mutated non-small cell lung cancer

by Patil V | Noronha V | Joshi A | Chougule A | Bhattacharjee A | Goel A | Talreja V | Menon N | Ramaswamy A | Karpe A | Pande N | Chandrasekharan A | Mahajan A | Janu A | Purandare N | Kumar P [Corresponding Author].

In Cancer Research, Statistics, and Treatment
Material type: article Article; Format: print Publisher: 2019Availability: Items available for loan: Tata Memorial Hospital (1).

32. Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patients

by Patil V | Joshi A | Noronha V | Bhattacharjee A | Dhumal S | Chandrakanth MV | Karpe A | Talreja V | Chandrasekharan A | Turkar S | Pande N | Ramaswamy A | Prabhash K [Corresponding author].

In South Asian Journal of Cancer
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

33. A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.

by Patil VM | Noronha V | Joshi A | Agarwal J | Ghosh-Laskar S | Budrukkar A | Murthy V | Gupta T | Mahimkar M | Juvekar S | Arya S | Mahajan A | Agarwal A | Purandare N | Rangarajan V | Balaji A | Chaudhari SV | Banavali S | Kannan S | Bhattacharjee A | D'Cruz AK | Chaturvedi P | Pai PS | Chaukar D | Pantvaidya G | Nair D | Nair S | Deshmukh A | Thiagarajan S | Mathrudev V | Manjrekar A | Dhumal S | Maske K | Bhelekar AS | Nawale K | Chandrasekharan A | Pande N | Goel A | Talreja V | Simha V | Srinivas S | Swami R | Vallathol DH | Dsouza H | Shrirangwar S | Turkar S | Abraham G | Thanky AH | Patel U | Pandey MK | Prabhash K [Corresponding Author].

In Cancer
Material type: article Article; Format: print Publisher: 2019Availability: Items available for loan: Tata Memorial Hospital (1).

34. Salvage surgery in head and neck cancer: Does it improve outcomes?

by Patil VM | Noronha V | Thiagarajan S | Joshi A | Chandrasekharan A | Talreja V | Agarwal J | Ghosh-Laskar S | Budrukkar A | Juvekar S | Mahajan A | Agarwal A | Purandare N | Bhattacharjee A | D'Cruz AK | Chaturvedi P | Pai PS | Chaukar D | Prabhash K [Corresponding Author].

In European Journal of Surgical Oncology
Material type: article Article; Format: print Publisher: 2020Availability: Items available for loan: Tata Memorial Hospital (1).

35. Splenic marginal zone lymphoma relapsing as miliary lung mottling: an unusual presentation

by Mandal T | Verma A | Talreja V | Parthiban SK | Gokarn A | Jain H | Bagal B | Tandon S | Sengar M | Shet T.

In Blood Research
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

36. Third-line therapy in the epidermal growth factor receptor mutation-positive advanced nonsmall-cell lung cancer

by Noronha V | Pande N | Joshi A | Patil V | Trivedi V | Chougule A | Amit J | Mahajan A | Talreja V | Prabhash K [Corresponding Author].

In South Asian Journal of Cancer
Material type: article Article; Format: print Publisher: 2020Availability: Items available for loan: Tata Memorial Hospital (1).

37. Toxicity and Tolerance of Concurrent Docetaxel with Radiotherapy in Cisplatin Ineligible Head and Neck Cancer Patients.

by Simha V | Patil V | Noronha V | Talreja V | Dhumal S | Chandrasekharan A | Shrirangwar S | Prabhash K.

In Journal of Clinical Oncology
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

38. Tyrosine kinase inhibitor versus physician choice chemotherapy in second-line epidermal growth factor receptor mutation non-small cell lung cancer: Post hoc analysis of randomized control trial

by Noronha V | Pandey A | Patil V | Joshi A | Choughule AB | Bhattacharjee A | Kumar R | Goud S | More S | Ramaswamy A | Karpe A | Pande N | Chandrasekharan A | Goel A | Talreja V | Mahajan A | Janu A | Purandare N | Prabhash K [Corresponding author].

In Indian Journal of Medical and Paediatric Oncology
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

Powered by Koha